Talking therapy for depression and anxiety ‘less effective for young adults'
Researchers warned there is an 'urgent need' to ensure the best possible mental healthcare for people aged 16-25 amid rising rates of mental health conditions.
NHS talking therapy for conditions like anxiety and depression can include cognitive behavioural therapy (CBT), counselling, and guided self-help using workbooks or online courses.
To explore ways in which services could be tailored to younger people, experts from University College London (UCL) analysed data from 1.5 million people who had attended NHS talking therapies in England between 2015 and 2019, including more than 309,758 people aged between 16 and 24.
Using self-reported scores from questionnaires taken before and after treatment, researchers found younger adults were 25% less likely to meet the threshold for reliable recovery after having talking therapy.
They were also 17% less likely to meet criteria for reliable improvement when compared to those aged 25-65.
Professor Argyris Stringaris, of UCL psychiatry, suggested people aged 16-24 may find it harder to regularly attend therapy sessions.
He said: 'Young people may find it harder to navigate services which have been set up for adults, and are more likely to miss sessions or stop attending altogether.
'Additionally, the late teens and early 20s are a point of transition for many people, which can involve plenty of stressful life events and changes that may make it more difficult to consistently attend.
'Working together with young people should help optimise the content of treatment and the ways in which it is delivered.
'Finally, young people may suffer from depression and anxiety problems that may differ somehow in their causes from those affecting adults; early onset depression could have different causes and may require different approaches to treatment. This is an area that requires a lot of new basic and clinical research.'
Researchers said the findings, published in Lancet Psychiatry, suggest future studies should consider tailoring mental health services to young people.
Dr Rob Saunders, of UCL psychology and language sciences, said: 'Talking therapy is an effective treatment for depression and anxiety disorders, and particularly tends to be preferred to pharmacological treatment by younger adults.
'Our analysis shows that talking therapies offered by the NHS are effective for younger adults, but as they are more effective for working-age adults, we believe there is work to be done to improve services for young adults.
'Rates of depression and anxiety in young adults are rising, so there is an urgent need to ensure we are offering them the best possible mental health care.'
The latest Adult Psychiatric Morbidity Survey, published in June, found more than a quarter of people aged 16-24 reported having so-called 'common mental health conditions', which include generalised anxiety disorder, depressive episodes, phobias, obsessive compulsive disorder (OCD) and panic disorder.
The figure was up from 17.5% in 2007.
An NHS spokesperson said: 'This study finds talking therapy is still helpful for young people and so we would urge them to come forward for care with our world-leading talking therapies service which provides evidence-based mental health support to more than a million people a year, with nine in 10 patients receiving support within six weeks.'
Olly Parker, head of external affairs and research at the charity YoungMinds, said: 'Growing up today is incredibly tough.
'Many young people are experiencing multiple pressures which impact their mental health, including poverty, inequality, intense academic pressure, and the online world. It's no wonder so many are struggling.
'We know many young people face long waits for mental health support and become more unwell while waiting, which can lead to needing more urgent care. We need to take an evidence-led approach to getting support right, ensuring young people are involved in choosing the treatments that work best for them.
'These findings must serve as another wake-up call to Government that urgent action is needed to reverse the decline in young people's mental health. This looks like a cross-government response that asks why so many young people are struggling, with radical solutions to address these root causes of poor mental health.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ITV News
10 minutes ago
- ITV News
Jersey women forced to travel for abortion face no financial help unless it is 'medically necessary'
Campaigners have hit out at Jersey's government as it was revealed that while proposed changes to the island's abortion law will allow longer for terminations, women will have to travel off-island for treatment after 13 weeks and pay for it themselves unless it is deemed "medically necessary". Those seeking an abortion from 13 weeks to 21 weeks and six days, which is the suggested new limit for most terminations, would have to foot the bill for the procedure, as well as travel to the UK and accommodation. The draft law states this is because abortions can only be performed in Jersey before 13 weeks due to "workforce constraints and the need to provide safe services" - there is an exception for urgent medical situations. Rachael Clarke from the UK's leading abortion care charity, the British Pregnancy Advisory Service, says Jersey lags behind other British Islands. She explains: "Unfortunately, Jersey seems to have made this decision that they don't want to help those women, even though their abortions would be legal if there were someone on island who could provide them. "That's an incredibly different position from what's in place in Guernsey and the Isle of Man, where if a woman needs an abortion that she can't access locally, she's funded to travel to England. "That's exactly what happens with all other forms of healthcare ... so the decision not to fund abortions seems to be specific and only because women's choices are being judged. "What we really need is government to step up and take responsibility." Ms Clarke says aspects of the proposed changes, such as legislating for women to access abortions later, are positive, but they only work if they can be put into practice. She adds: "In essence, it's completely pointless to change the law for women if you're not going to enable them to access the services that the law allows. "We're talking about such a small number but for those women, the impact on their lives of having to continue a pregnancy and raise a child that they really would have preferred not to is incredibly difficult." Ms Clarke says private abortions can cost up to £1,500 in the UK, without factoring in travel and accommodation, as the Government has confirmed that Jersey residents are not entitled to free NHS terminations. Abortions under 13 weeks can be carried out in Jersey and cost £185 for women who have lived in the island for at least six months. Some can also receive this on-island treatment for free, such as those on income support, aged under 18, in full-time education, or pregnant as a result of rape or incest. However, these groups are not covered after 13 weeks and would face the same travel and treatment fees, unless there is a medical exemption. In response to concerns over the draft law, Deputy Andy Howell, Jersey's Assistant Health Minister, says: "I'm really sorry but we just can't pay for everything, but we want people to know that if you go early then it's much less traumatic and we've got a really lovely councillor who can help you and is there at all times. "Try to go early, try to recognise that you might be pregnant early and then seek help." Deputy Howell adds: "I understand the concerns some islanders may have, however, very few Jersey residents have non-medically necessary terminations in the UK. "In 2022, the last available data, fewer than five Jersey residents had terminations in the UK, which includes women having medically necessary terminations. "Women are, instead, opting for earlier stage terminations in Jersey, which are lower risk than later-stage terminations, so our priority is to support access to those terminations." The proposition is expected to be brought to the States for debate by the end of the year.
The Guardian
11 minutes ago
- The Guardian
Daily pill helps patients lose 12% of body weight in early trial
A daily weight-loss pill has been shown to help patients lose about 12% of their body weight, according to the results of a clinical trial. The drug, made by the pharmaceutical company Eli Lilly, is a GLP-1 agonist – a type of medication that helps lower blood sugar levels, reduces appetite and slows digestion. More than 3,000 people took part in the 72-week study. Those who received the highest dose – 36mg of orforglipron – lost on average 12.4% of their body weight, compared with just 0.9% of the control group. The trial also showed other health benefits for users, including improvements to cholesterol, blood pressure and heart disease risk. The results come after Novo Nordisk's oral weight loss drug, which has been submitted for approval in the US, helped trial participants lose about 15% of their body weight. Eli Lilly manufactures Mounjaro, a once-a-week injection that contains the drug tirzepatide, which is also used to help improve blood sugar in people with type 2 diabetes. A weight loss pill could offer a more convenient and cheaper alternative – for both patients and the NHS – to injectable treatments that are being rolled out across England. The trial has not yet been peer reviewed and its results are preliminary. Kenneth Custer, the president of Eli Lilly, said: 'With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments. 'With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need.' Dr Simon Cork, a senior lecturer in physiology at Anglia Ruskin University, said although the preliminary results of the effectiveness were a 'positive step forward', they should be interpreted with caution. He said: 'It should be noted that their effects on weight loss are not as profound as that seen in injectable GLP-1 receptor agonists, such as Wegovy, with a lower percentage weight loss and fewer people achieving 10% weight loss at the highest dose. 'It should be noted that these are preliminary, non-peer reviewed results and we will need to see the full trial methodology and data before a more comprehensive analysis can be undertaken.'
Daily Mail
41 minutes ago
- Daily Mail
NHS under fire for delaying a ban on trans-women using female-only wards, changing rooms and toilets until the autumn
The NHS has come under fire for delaying a ban on trans-women using female-only wards, changing rooms and toilets until the autumn. Health secretary Wes Streeting promised new guidance in April, after the Supreme Court ruled biological men should be barred from women's single-sex spaces. But NHS England has no plans to bring out the guidance until 'late summer or early autumn', meaning it may not be published until October or November. Women's rights charities said hospitals and GP surgeries are putting females in an 'undignified and humiliating' position by failing to comply with the law. The group Sex Matters told the Telegraph it has been contacted by staff at several English trusts who had raised objections to biological men in female facilities but were rebuffed. NHS England's delay comes even though a health trust in Scotland faces making a huge payout to a nurse who was forced to share a changing room with a trans doctor. Helen Joyce, the director of advocacy at Sex Matters, said: 'NHS England's failure to forbid unlawful policies permitting trans-identifying hospital staff to use changing rooms for the opposite sex is staggeringly complacent. 'Sex Matters has heard from staff in several English trusts who have objected to such self-ID policies without success. 'All around the country, it seems as if lazy, self-satisfied bureaucrats are leaving female staff to face undignified and humiliating conditions rather than admit that the 'inclusive' policies they put in place were always unlawful and harmful to women.' The Supreme Court ruled that a trans woman was not legally a woman because the word 'sex' in the Equality Act refers to biological sex, not self-identified gender. It means services segregated by sex, such as toilets and changing rooms, should be segregated by biological sex. Many public bodies have already started observing the rules. But NHS England has still not acted, despite prime minister Sir Keir Starmer telling organisations to comply with the law 'as soon as possible'. The national NHS guidance on same-sex accommodation, published in September 2019, says: 'Good practice requires that clinical responses be patient-centred, respectful and flexible towards all transgender people whether they live continuously or temporarily in a gender role that does not conform to their natal sex.' It adds: 'Trans people should be accommodated according to their presentation: the way they dress, and the name and pronouns they currently use. 'This may not always accord with the physical sex appearance of the chest or genitalia. 'It does not depend on their having a gender recognition certificate or legal name change.' The NHS Confederation, which represents trusts and other health organisations, withdrew its guidance two months ago. The original guidance said trans people should be allowed to use their chosen toilets and changing rooms. Ms Joyce said NHS trusts faced huge pay-outs if they did not update their guidance to comply with the law. In Fife, the NHS is defending itself in an employment tribunal against nurse Sandie Peggie, who was suspended after objecting to a trans woman in the changing room. Ms Joyce said: 'In Scotland, NHS Fife has already wasted hundreds of thousands of pounds defending an employment tribunal brought by nurse Sandie Peggie. 'The eventual cost, which will be borne by taxpayers, could approach £1m. 'How many more Sandie Peggies have to put their reputations and livelihoods on the line before this ends?' Baroness Falkner, chair of the Equality and Human Rights Commission, said in April: 'We've been speaking to the health service for an inordinately long time - we will now be asking them when they will be updating their advice.' NHS England said: 'The NHS is working through the implications of the ruling, and we absolutely recognise the need for revised guidance. 'It's important for the Equality and Human Rights Commission to publish its statutory guidance before final decisions about future policy are taken. 'In the meantime, we are working closely with Government to ensure we can provide updated guidance as soon as possible.'
